{
  "nctId": "NCT02088372",
  "briefTitle": "Prospective Multi-Center Study on Vanguard With E1 Bearing",
  "officialTitle": "Evaluate Clinical Performance of Vanguard Knee With E1 Bearing in Korean Patient Population",
  "protocolDocument": {
    "nctId": "NCT02088372",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2013-02-15",
    "uploadDate": "2018-06-24T21:03",
    "size": 336521,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02088372/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 200,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2012-11",
    "completionDate": "2021-02",
    "primaryCompletionDate": "2014-12",
    "firstSubmitDate": "2014-03-13",
    "firstPostDate": "2014-03-14"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\nPatients will be included in this study if they received Vanguard knee with E1 Bearing per the approved indications for use for Vanguard Knee. Specifically\n\n* Painful and disabled knee joint resulting from osteoarthritis or traumatic arthritis where one or more compartments are involved\n* Correction of varus, valgus, or posttraumatic deformity\n* Correction or revision of unsuccessful osteotomy\n\nExclusion Criteria:\n\nExclusion Criteria for this study should comply with the stated contraindications on package inserts of Vanguard™ Knee and the E1™ Tibial Bearing. These indications are stated below:\n\nAbsolute contraindications include: infection, sepsis, osteomyelitis, and failure of a previous joint replacement\n\nRelative contraindications include:\n\n* Uncooperative patient or patient with neurologic disorders who are incapable of following directions,\n* Osteoporosis\n* Metabolic disorders which may impair bone formation\n* Osteomalacia\n* Distant foci of infections which may spread to the implant site\n* Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram\n* Vascular insufficiency, muscular atrophy, neuromuscular disease\n* Incomplete or deficient soft tissue surrounding the knee",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "20 Years",
    "maximumAge": "80 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Knee Society Score",
        "description": "scoring system to rate the knee and patient's functional abilities such as walking and stair climbing before and after TKA",
        "timeFrame": "1 year"
      }
    ],
    "secondary": [
      {
        "measure": "Knee Sociey Score",
        "description": "scoring system to rate the knee and patient's functional abilities such as walking and stair climbing before and after TKA",
        "timeFrame": "6 Months"
      },
      {
        "measure": "Knee Society Score",
        "description": "scoring system to rate the knee and patient's functional abilities such as walking and stair climbing before and after TKA",
        "timeFrame": "3 Years"
      },
      {
        "measure": "Knee Society Score",
        "description": "scoring system to rate the knee and patient's functional abilities such as walking and stair climbing before and after TKA",
        "timeFrame": "5 Years"
      },
      {
        "measure": "KOOS",
        "description": "Knee injuries \\& Osteoarthritis Outcome Score",
        "timeFrame": "6 Months"
      },
      {
        "measure": "KOOS",
        "description": "Knee injuries \\& Osteoarthritis Outcome Score",
        "timeFrame": "1 Year"
      },
      {
        "measure": "KOOS",
        "description": "Knee injuries \\& Osteoarthritis Outcome Score",
        "timeFrame": "3 Years"
      },
      {
        "measure": "KOOS",
        "description": "Knee injuries \\& Osteoarthritis Outcome Score",
        "timeFrame": "5 Years"
      },
      {
        "measure": "EQ5D",
        "description": "standardised instrument for use as a measure of health outcome.",
        "timeFrame": "6 Months"
      },
      {
        "measure": "EQ5D",
        "description": "standardised instrument for use as a measure of health outcome.",
        "timeFrame": "1 Year"
      },
      {
        "measure": "EQ5D",
        "description": "standardised instrument for use as a measure of health outcome.",
        "timeFrame": "3 Years"
      },
      {
        "measure": "EQ5D",
        "description": "standardised instrument for use as a measure of health outcome.",
        "timeFrame": "5 Years"
      },
      {
        "measure": "Modified University of California Los Angeles (UCLA) Activity Score",
        "description": "It asks patients to rate their activity level from 1 to 10, with 1 defined as \"no physical activity\" and 10 defined as \"regular participation in impact sports\".\n\nThe UCLA scale has demonstrated construct validity, excellent reliability, and the best completion rates.",
        "timeFrame": "6 Months"
      },
      {
        "measure": "Modified University of California Los Angeles (UCLA) Activity Score",
        "description": "It asks patients to rate their activity level from 1 to 10, with 1 defined as \"no physical activity\" and 10 defined as \"regular participation in impact sports\".\n\nThe UCLA scale has demonstrated construct validity, excellent reliability, and the best completion rates.",
        "timeFrame": "1 Year"
      },
      {
        "measure": "Modified University of California Los Angeles (UCLA) Activity Score",
        "description": "It asks patients to rate their activity level from 1 to 10, with 1 defined as \"no physical activity\" and 10 defined as \"regular participation in impact sports\".\n\nThe UCLA scale has demonstrated construct validity, excellent reliability, and the best completion rates.",
        "timeFrame": "3 Years"
      },
      {
        "measure": "Modified University of California Los Angeles (UCLA) Activity Score",
        "description": "It asks patients to rate their activity level from 1 to 10, with 1 defined as \"no physical activity\" and 10 defined as \"regular participation in impact sports\".\n\nThe UCLA scale has demonstrated construct validity, excellent reliability, and the best completion rates.",
        "timeFrame": "5 Years"
      },
      {
        "measure": "Radiographic Assessment",
        "description": "Radiographic Evaluation",
        "timeFrame": "Immediate Post-op(2 - 4 Weeks)"
      },
      {
        "measure": "Radiographic Assessment",
        "description": "Radiographic Evaluation",
        "timeFrame": "6 Months"
      },
      {
        "measure": "Radiographic Assessment",
        "description": "Radiographic Evaluation",
        "timeFrame": "1 Year"
      },
      {
        "measure": "Radiographic Assessment",
        "description": "Radiographic Evaluation",
        "timeFrame": "3 Years"
      },
      {
        "measure": "Radiographic Assessment",
        "description": "Radiographic Evaluation",
        "timeFrame": "5 Years"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 20,
      "otherCount": 0,
      "totalCount": 21
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 100,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:58.461Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}